Supplier News

Oct 20, 2017
By Pharmaceutical Technology Editors
The companies will embark on a joint antimicrobial research project, with the intent to discover antibiotic combinations that target resistance.
Oct 20, 2017
By Pharmaceutical Technology Editors
The company has announced that it has acquired a new bioanalysis and biomarkers services facility in Laval, Montreal, Canada to support preclinical and clinical programs.
Oct 20, 2017
By Pharmaceutical Technology Editors
SCHOTT began production of glass ampoules, vials, and cartridges at a new facility at the SCHOTT Xinkang headquarters in Zhejiang, China.
Oct 19, 2017
By Pharmaceutical Technology Editors
The two companies announced their collaboration for the production and development of cancer vaccines.
Oct 17, 2017
By Pharmaceutical Technology Editors
DSM Sinochem Pharmaceuticals has filed a lawsuit against CSPC Pharmaceutical Group, Inner Mongolia Changsheng Pharmaceutical Company, and CSPC Zhangnuo Pharmaceutical (Shijiazhuang) for infringement of its amoxicillin patent.
Oct 17, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Almac Group’s Almac Pod, a temperature-controlled shipping solution service for biologics and other temperature-sensitive products, is available in the United States.
Oct 17, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
CordenPharma will expand development capacity for small molecules, peptides, and carbohydrates at its Liestal, Switzerland site
Oct 16, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Piramal is investing $55 million into the expansion of its API manufacturing capabilities and capacities across sites in North America and Asia.
Oct 16, 2017
By Pharmaceutical Technology Editors
The company announced plans to expand its viral vector process development facilities in the United States and its cleanroom facilities in the Netherlands for vector-based products.
Oct 16, 2017
By Pharmaceutical Technology Editors
Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.
native1_300x100
lorem ipsum